Video Latest - ecancer

Considerations to make when communicating genomic information

Dr Terri McVeigh - The Royal Marsden NHS Foundation Trust, London, UK

10 Mar 2023

Rationale for routine use of IORT for early breast cancer and data for specific indications

Dr Hans-Christian Kolberg - Marienhospital Bottrop gGmbH, Bottrop, Germany

9 Mar 2023

Single-dose IORT during lumpectomy for breast cancer an innovative patient-centred treatment

Dr Jayant Vaidya - University College London, London, UK

9 Mar 2023

Global adoption of single-shot targeted IORT for breast cancer

Dr Jayant Vaidya - University College London, London, UK

9 Mar 2023

IORT at the Asian Hospital and Medical Center

Dr Aldine Basa - Asian Hospital and Medical Center, Manila, Philippines

9 Mar 2023

The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival

Dr Jayant Vaidya - University College London, London, UK

9 Mar 2023

Insights from TARGIT-A trial of targeted IORT during lumpectomy for breast cancer

Dr Jayant Vaidya - University College London, London, UK

9 Mar 2023

Choosing Wisely in radiology

Dr Iramu Revelian - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

9 Mar 2023

Choosing Wisely in radiotherapy

Dr Sikudhani Muya - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

9 Mar 2023

Choosing Wisely in pathology

Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

8 Mar 2023

Latest in PARP inhibitors and combination therapies for prostate cancer

Dr Dan George, Prof Noel Clarke, Dr Friederike Schlurmann and Prof Eleni Efstathiou

19 Feb 2023

3 year follow-up of the CheckMate 9ER trial: NIVO + cabozantinib vs sunitinib for first-line treatment of aRCC

Dr Mauricio Burotto - Bradford Hill, Recoleta, Chile

19 Feb 2023

Video